Skip to main content

Table 5 Impact of generic substitution on the range of sales packages on the market in the pharmaceutical companies.

From: The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland

 

Survey 2004

Survey 2008

 

Original product companies

n (%)

Generic product companies

n (%)

Total

n (%)

P-value

Original product companies

n (%)

Generic product companies

n (%)

Total

n (%)

P-value

Has generic substitution influenced the number of different sales packages of pharmaceutical products on the pharmaceutical market in your company?*

   

0.318

   

0.347

No

8 (53)

4 (57)

12 (54)

 

8 (57)

2 (33)

10 (50)

 

The number of packages has decreased

7 (47)

2 (29)

9 (41)

 

5 (36)

2 (33)

7 (35)

 

The number of packages has increased

-

1 (14)

1 (5)

 

1 (7)

2 (33)

3 (15)

 

Total

15 (100)

7 (100

22 (100)

 

14 (100)

6 (100)

20 (100)

 
  1. * P-value between the 2004 and 2008 surveys in the original product companies (p = 0.710) and in the generic product companies (p = 0.790)